Canine stem cell factor augments expression of matrix metalloproteinase-9 by CD34 cells

References

• Krause DS, Fackler MJ, Civin CI, et al. CD34: structure, biology and clinical utility. Blood 1996; 87: 1–13
   PubMed Web of Science ®Google Scholar
• Ladiges WC, Storb R, Thomas ED. Canine models of bone marrow transplantation. Lab Anim Sci 1990; 40: 11–15
   Google Scholar
• Wagner JL, Storb R. Preclinical large animal models for hematopoietic stem cell transplantation. Curr Opin Hemtatol 1996; 3: 410–15
   PubMedGoogle Scholar
• McSweeney PA, Rouleau KA, Wallace PM, et al. Characterization of monoclonal antibodies that recognize canine CD34. Blood 1998; 91: 1977–86
   PubMed Web of Science ®Google Scholar
• Wijewardana V, Sugiura K, Shigeyama N, et al. Isolation and characterization of hematopoietic progenitor cells in canine bone marrow. Vet Immunol Immunopathol 2007; 115: 230–8
   PubMed Web of Science ®Google Scholar
• Janowska-Wieczorek A, Marquez LA, Dobrowsky A, et al. Differential MMP and TIMP production by human marrow and peripheral blood CD34+ cells in response to chemokines. Exp Hematol 2000; 28: 1274–85
   PubMed Web of Science ®Google Scholar
• Forraz N, Pettengell R, McGuckin CP. Characterization of a linage-negative stem-progenitor cell population optimized for ex vivo expansion and enriched for LTC-IC. Stem Cells 2004; 22: 100–8
   PubMed Web of Science ®Google Scholar
• Nilsson SK, Simmons PJ, Bertoncello I. Hemopoietic stem cell engraftment. Exp Hematol 2006; 34: 123–9
   PubMed Web of Science ®Google Scholar
• Janowska-Wieczorek A, Marquez LA, Nabholtz JM, et al. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34+ cells and their transmigration through reconstituted basement membrane. Blood 1999; 93: 3379–90
   PubMed Web of Science ®Google Scholar
• Zheng Y, Watanabe N, Nagamura-Inoue T, et al. Ex vivo manipulation of umbilical cord blood-derived hematopoietic stem/progenitor cells with recombinant human stem cell factor can up-regulate levels of homing-essential molecules to increase their transmigratory potential. Exp Hematol 2003; 31: 1237–46
   PubMed Web of Science ®Google Scholar
• Lapidot T, Dar A, Kollet O. How do stem cells find their way home?. Blood 2005; 106: 1901–10
   PubMed Web of Science ®Google Scholar
• Peck SC, Nühse TS, Hess D, et al. Directed proteomics identifies a plant-specific protein rapidly phosphorylated in response to bacterial and fungal elicitors. Plant Cell 2001; 13: 1467–75
   PubMed Web of Science ®Google Scholar
• Fermín ML, Gaitán S, Fragío C, et al. Canine long-term bone marrow culture neutrophil production and functionality. Acta Haematol 2004; 111: 196–204
   PubMed Web of Science ®Google Scholar
• León LG, Ostronoff LK, Fermín ML, et al. In vitro generation of mature neutrophils from canine Lin– bone marrow cells. Vet Immunol Inmunopathol 2005; 107: 41–50
   PubMed Web of Science ®Google Scholar
• Cobbold S, Metcalfe S. Monoclonal antibodies that define canine homologues of human CD antigens: summary of the First International Canine Leukocyte Antigen Workshop (CLAW). Tissue Antigens 1994; 43: 137–54
   PubMedGoogle Scholar
• Neuner E, Schumm M, Schneider EM, et al. Immune phenotype of canine hematopoietic progenitor cells. Tissue Antigens 1997; 50: 466–74
   PubMedGoogle Scholar
• Janowska-Wieczorek A, Matsuzaki A, Marquez LA. Matrix metalloproteinases in the hematopoietic microenvironment. Hematology 2000; 4: 515–27
   PubMedGoogle Scholar
• Rao Q, Zheng GG, Lin YM, et al. Production of matrix metalloproteinase-9 by cord blood CD34+ cells and its role in migration. Ann Hematol 2004; 83: 409–13
   PubMed Web of Science ®Google Scholar
• Byk T, Kahn J, Kollet O, et al. Cycling G1 CD34 + /CD38+ cells potentiate the motility and engraftment of quiescent G0 CD34 + /CD38–/low severe combined immunodeficiency repopulating cells. Stem Cells 2005; 23: 561–74
   PubMed Web of Science ®Google Scholar
• Civin CI, Strauss LC, Brovall C, et al. Antigenic analysis of hematopoiesis. III. A hematopoietic progenitor cell surface antigen defined by a monoclonal antibody raised against KG-1a cells. J Immunol 1984; 133: 157–65
   PubMed Web of Science ®Google Scholar
• Andrews RG, Singer JW, Bernstein ID. Monoclonal antibody 12.8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors. Blood 1986; 67: 842–5
   PubMed Web of Science ®Google Scholar
• Layton DS, Strom ADG, O'Neil TE, et al. Development of an anti-porcine CD34 monoclonal antibody that identifies hematopoietic stem cells. Exp Hematol 2007; 35: 171–8
   PubMed Web of Science ®Google Scholar
• Nimgaonkar MT, Roscoe RA, Persichetti J, et al. A unique population of CD34+ cells in cord blood. Stem Cells 1995; 13: 158–66
   PubMed Web of Science ®Google Scholar
• Bruno B, Nash RA, Wallace PM, et al. CD34 selected bone marrow grafts are radioprotective and establish mixed chimerism in dogs given high dose total body irradiation. Transplantation 1999; 68: 338–44
   PubMed Web of Science ®Google Scholar
• Sieburg HB, Cho RH, Muller-Sieburg CE. Limiting dilution analysis for estimating the frequency of hematopoietic stem cells: uncertainty and significance. Exp Hematol 2002; 30: 1436–43
   PubMed Web of Science ®Google Scholar
• Janowska-Wieczorek A, Majka M, Ratajczak J, et al. Autocrine/paracrine mechanism in human hematopoiesis. Stem Cells 2001; 19: 99–107
   PubMed Web of Science ®Google Scholar